Kevin J. Ballinger, EVP & President, Interven Cardio at BOSTON SCIENTIFIC CORP (BSX), sold 37,430 shares at $38.00 ($1.4M) on 2018-09-24, disclosed to the SEC on 2018-09-25.
Open-market sale of $1.4M BSX by EVP & President, Interven Cardio. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BSX | SELL | 2020-03-03 | $1.2M | — | Filing → |
| BSX | SELL | 2020-02-26 | $466K | — | Filing → |
| BSX | SELL | 2020-02-19 | $149K | — | Filing → |